<DOC>
	<DOCNO>NCT01034904</DOCNO>
	<brief_summary>The relevance study establish whether Health Related Quality Life ( HRQoL ) measure obtain repeatedly hemophilia care sensitive significant change health personal circumstance relate transition youth adulthood . This may support future use HRQoL measure part routine care order identify important change detectible clinical mean .</brief_summary>
	<brief_title>Health Related Quality Life Youth Young Adults With Hemophilia A</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Moderate severe Hemophilia A ( factor level â‰¤5 % ) Receiving Helixate FS ondemand treatment prophylaxis therapy time informed consent Patient age 14 29 year time recruitment Complete inform consent process documentation ; ( Patients age 18 must assent addition consent legal guardian ) Willing/able follow study protocol , include keep bleeding treatment diary Able communicate clearly either English French write verbal communication essential . Known inhibitor time recruitment ( &gt; 0,5 Bethesda unit ) immune tolerance therapy time recruitment HIV positive Symptomatic Hepatitis B C infection active treatment hepatitis B C Inability comply study protocol Hypersensitivity Helixate FS ingredient formulation component container Hypersensitivity mouse hamster protein Unsuitable participate study reason assess investigator</criteria>
	<gender>Male</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Quality Life</keyword>
	<keyword>HRQoL</keyword>
	<keyword>Hemophilia A</keyword>
	<keyword>Helixate FS</keyword>
</DOC>